Adicet Bio, Inc. (ACET)

Adicet Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	38.92	56.5	159.71	257.66	277.54
Short-Term Investments	119.61	119.81	-	-	-
Cash & Short-Term Investments	158.53	176.3	159.71	257.66	277.54
Cash Growth	-10.08%	10.39%	-38.01%	-7.17%	193.34%
Accounts Receivable	-	-	-	-	0.19
Other Current Assets	2.4	3.83	2.56	3.38	4.71
Total Current Assets	160.93	180.14	162.27	261.04	282.44
Net Property, Plant & Equipment	28.48	36.75	44.2	48.98	35
Goodwill	-	-	-	19.46	19.46
Other Long-Term Assets	2.95	3.33	0.82	1.21	2.04
Total Assets	192.36	220.22	207.3	330.69	338.94
Accounts Payable	4.74	4.83	2.63	4.4	3.26
Accrued Expenses	13.61	11.43	13.44	12.81	6.68
Current Portion of Leases	3.19	3.13	3.22	2.49	1.57
Unearned Revenue	-	-	-	-	4.81
Total Current Liabilities	21.53	19.39	19.29	19.71	16.32
Long-Term Leases	11.55	14.1	17.7	18.53	19.38
Other Long-Term Liabilities	0.06	0.12	0.13	0.11	0.12
Total Long-Term Liabilities	11.61	14.22	17.83	18.65	19.49
Total Liabilities	33.15	33.61	37.12	38.35	35.81
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	773.8	684.48	550.94	530.45	471.45
Accumulated Other Comprehensive Income	0.1	0.02	-	-	-
Retained Earnings	-614.7	-497.89	-380.77	-238.11	-168.32
Shareholders' Equity	159.21	186.61	170.18	292.34	303.13
Total Liabilities & Equity	192.36	220.22	207.3	330.69	338.94
Total Debt	14.74	17.23	20.92	21.02	20.94
Net Cash (Debt)	143.79	159.07	138.79	236.63	256.6
Net Cash Growth	-9.60%	14.61%	-41.35%	-7.78%	251.63%
Net Cash Per Share	20.87	28.97	51.59	92.16	132.64
Book Value	159.21	186.61	170.18	292.34	303.13
Book Value Per Share	23.10	33.98	63.26	113.86	156.70
Tangible Book Value	159.21	186.61	170.18	272.88	283.67
Tangible Book Value Per Share	23.10	33.98	63.26	106.28	146.64

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q